GRIFOLS | GRF - Sales Revenues

Stock Price
8.95
Daily Change
0.002 0.02%
Monthly
1.45%
Yearly
7.06%
Q2 Forecast
8.72

GRIFOLS reported EUR1.98B in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Alcon AG USD 2.7B 110M Dec/2025
Almirall EUR 547.63M 12.83M Dec/2025
Amadeus IT EUR 1.62B 18.3M Dec/2025
Amarin USD 49.22M 451K Dec/2025
argenx SE USD 1.12B 132.91M Dec/2025
AstraZeneca USD 15.5B 313M Dec/2025
Bayer EUR 11.44B 1.78B Dec/2025
Cie Automotive EUR 1.96B 984.2M Dec/2025
Demant DKK 6.26B 810M Dec/2025
Ence Energia y Celulosa EUR 187.15M 6.25M Dec/2025
Essilor EUR 14.47B 7.6B Dec/2025
Ferrovial EUR 2.72B 306M Dec/2025
Fresenius EUR 5.88B 400M Dec/2025
Fresenius Medical Care EUR 5.07B 180M Dec/2025
Galapagos EUR 900.82M 835.52M Dec/2025
Genmab DKK 1.06B 36M Dec/2025
GlaxoSmithKline GBP 8.62B 73M Dec/2025
GRIFOLS EUR 1.98B 110M Dec/2025
Hikma Pharmaceutical USD 1.69B 863M Dec/2025
Inditex EUR 11.69B 1.88B Dec/2025
Merck EUR 5.25B 70M Dec/2025
Novartis USD 13.11B 226M Mar/2026
Philips EUR 5.1B 797M Dec/2025
Roche Holding CHF 15.65B 274.5M Dec/2025
Sanofi EUR 11.24B 60M Mar/2026
Smith & Nephew USD 3.18B 353M Dec/2025
UCB EUR 4.25B 764M Dec/2025
Viscofan EUR 305M 10.12M Mar/2026